Compounds That Target ABL2

ABL proto-oncogene 2, non-receptor tyrosine kinase · 172 compounds in BiohacksAI corpus

ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) is a biological target with 172 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into ABL2 modulation for therapeutic and biohacking applications.

View ABL2 target page →UniProt: P42684 ↗

All 50 Compounds — Ranked by Evidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Imatinib

5.47

confidence

Ibrutinib

4.86

confidence

Cabozantinib

4.39

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Vandetanib

4.30

confidence

Ponatinib

4.26

confidence

Nilotinib

4.17

confidence

Bosutinib

4.08

confidence

Doramapimod

4.06

confidence

Pazopanib

3.69

confidence

Nintedanib

3.61

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Bms 777607

3.37

confidence

Mln 8054

3.33

confidence

Saracatinib

3.33

confidence

Dabrafenib

3.30

confidence

Neflamapimod

3.30

confidence

Alisertib

3.30

confidence

Dovitinib

3.09

confidence

At 9283

3.09

confidence

Dasatinib Anhydrous

3.09

confidence

Lestaurtinib

3.04

confidence

Pf 03758309

3.00

confidence

Danusertib

2.94

confidence

R 406

2.83

confidence

Cediranib

2.83

confidence

Milciclib

2.77

confidence

Masitinib

2.77

confidence

Pha 665752

2.71

confidence

Plx 4720

2.71

confidence

Kw 2449

2.64

confidence

Tivozanib

2.64

confidence

Ast 487

2.56

confidence

Atuveciclib

2.56

confidence

Raf 265

2.48

confidence

Motesanib

2.48

confidence

Brivanib

2.48

confidence

Mk 5108

2.48

confidence

Azd 7762

2.30

confidence

Aee 788

2.30

confidence

Rebastinib

2.20

confidence

Golvatinib

2.20

confidence

Decernotinib

2.20

confidence

Glesatinib

2.08

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: ABL2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.